ai-for-science
AI Is Rewriting the Odds of Drug Development
a16z argues AI could alter drug hit rates and development timelines, but without clinical validation it remains a commercial option, not a proven infl
2 articles tagged with this topic
a16z argues AI could alter drug hit rates and development timelines, but without clinical validation it remains a commercial option, not a proven infl
Fedus, ChatGPT co-creator, leaves OpenAI, co-founds Periodic Labs with DeepMind materials lead, betting on closed-loop AI for superconductors.